Close

ANIK Financial Facts

Cost of product revenue: 5M
Net income: 0.61
See Full Income Statement

Total stockholders' equity: 214.54M
Total Assets: 231.06M
See Full Balance Sheet

Anika Therapeutics Inc. (ANIK) Earnings

  |   Expand Research on ANIK
Next EPS Date 5/2/24 EPS Growth Rate -63.6%
Average EPS % Beat Rate +98.7% Revenue Growth Rate +9.6%
Average % Move 1-Wk after EPS -1.4% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/2/23 Q323 $0.00-$0.35 +$0.35$41.5M$38.27M = Details
8/8/23 Q223 $0.06-$0.32 +$0.38$44.3M$40.37M = Details
5/9/23 Q123 -$0.11-$0.24 +$0.13$37.9M$38.95M = Details
2/23/23 Q422 N/A-$0.24 N/A N/A$37.71M N/A N/A N/A
3/6/23 Q422 -$0.34-$0.24 -$0.10$39.62M$37.71M = Details
3/13/24 Q423 $0.05-$0.23 +$0.28$43M$41.4M = Details
2/22/24 Q423 N/A-$0.23 N/A N/A$41.4M = N/A N/A
11/8/22 Q322 $0.04-$0.23 +$0.27$39.54M$38.11M N/A Details